![](/img/cover-not-exists.png)
A novel therapeutic vaccine composed of a rearranged human papillomavirus type 16 E6/E7 fusion protein and Fms-like tyrosine kinase-3 ligand induces CD8 + T cell responses and antitumor effect
Li, Jianqiang, Chen, Si, Ge, Jun, Lu, Feng, Ren, Sulin, Zhao, Zhiqiang, Pu, Xiuying, chen, Xiaoxiao, Sun, Jiaojiao, Gu, YueqingLanguage:
english
Journal:
Vaccine
DOI:
10.1016/j.vaccine.2017.09.003
Date:
October, 2017
File:
PDF, 1.68 MB
english, 2017